Chinese Journal of Stroke ›› 2021, Vol. 16 ›› Issue (12): 1278-1283.DOI: 10.3969/j.issn.1673-5765.2021.12.014
Previous Articles Next Articles
Received:
2021-10-07
Online:
2021-12-20
Published:
2021-12-20
吴娟娟, 倪俊
通讯作者:
倪俊 pumchnijun@163.com
基金资助:
WU Juanjuan, NI Jun. Advances in the Mechanism of Cerebral Amyloid Angiopathy[J]. Chinese Journal of Stroke, 2021, 16(12): 1278-1283.
吴娟娟, 倪俊. 脑淀粉样血管病发病机制的研究进展[J]. 中国卒中杂志, 2021, 16(12): 1278-1283.
[1] JAUNMUKTANE Z,QUAEGEBEUR A,TAIPA R,et al. Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery[J]. Acta Neuropathol,2018,135(5):671-679. [2] EISENBERG D,JUCKER M. The amyloid state of proteins in human diseases[J]. Cell,2012,148(6): 1188-1203. [3] BENSON M D,BUXBAUM J N,EISENBERG D S,et al. Amyloid nomenclature 2020:update and recommendations by the International Society of Amyloidosis(ISA)nomenclature committee[J]. Amyloid,2020,27(4):217-222. [4] HERVAS R,RAU M J,PARK Y,et al. Cryo- EM structure of a neuronal functional amyloid implicated in memory persistence in Drosophila[J]. Science,2020,367(6483):1230-1234. [5] YAMADA M. Cerebral amyloid angiopathy: emerging concepts[J]. J Stroke,2015,17(1):17-30. [6] SHARMA R,DEARAUGO S,INFELD B,et al. Cerebral amyloid angiopathy:review of clinicoradiological features and mimics[J]. J Med Imaging Radiat Oncol,2018,62(4):451-463. [7] ATTEMS J,JELLINGER K A,LINTNER F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy[J]. Acta Neuropathol,2005,110(3): 222-231. [8] GREENBERG S M,CHARIDIMOU A. Diagnosis of cerebral amyloid angiopathy:evolution of the Boston criteria[J]. Stroke,2018,49(2):491-497. [9] PANZA F,LOZUPONE M,SOLFRIZZI V,et al. BACE inhibitors in clinical development for the treatment of Alzheimer's disease[J]. Expert Rev Neurother,2018,18(11):847-857. [10] MENDEL T A,WIERZBA-BOBROWICZ T, LEWANDOWSKA E,et al. The development of cerebral amyloid angiopathy in cerebral vessels. A review with illustrations based upon own investigated post mortem cases[J]. Pol J Pathol,2013, 64(4):260-267. [11] GIREUD-GOSS M,MACK A F,MCCULLOUGH L D,et al. Cerebral amyloid angiopathy and bloodbrain barrier dysfunction[J]. Neuroscientist,2021,27 (6):668-684. [12] MATSUOKA Y,SAITO M,LAFRANCOIS J,et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid[J]. J Neurosci, 2003,23(1):29-33. [13] KALARIA R N,PREMKUMAR D R,PAX A B,et al. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels,meningeal vessels and choroid plexus in Alzheimer's disease[J]. Brain Res Mol Brain Res, 1996,35(1/2):58-68. [14] TARASOFF-CONWAY J M,CARARE R O, OSORIO R S,et al. Clearance systems in the brainimplications for Alzheimer disease[J]. Nat Rev Neurol,2015,11(8):457-470. [15] GREENBERG S M,BACSKAI B J, HERNANDEZ-GUILLAMON M,et al. Cerebral amyloid angiopathy and Alzheimer disease-one peptide,two pathways[J]. Nat Rev Neurol,2020,16 (1):30-42. [16] ALBARGOTHY N J,JOHNSTON D A, MACGREGOR-SHARP M,et al. Convective influx/ glymphatic system:tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways[J]. Acta Neuropathol, 2018,136(1):139-152. [17] MESTRE H,TITHOF J,DU T,et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension[J]. Nat Commun, 2018,9(1):4878. [18] ALDEA R,WELLER R O,WILCOCK D M,et al. Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain[J/OL]. Front Aging Neurosci,2019,11:1[2021-10-02]. https://doi.org/10.3389/fnagi.2019.00001. [19] VAN VELUW S J,HOU S S,CALVORODRIGUEZ M,et al. Vasomotion as a driving force for paravascular clearance in the awake mouse brain[J/OL]. Neuron,2020,105(3):549-561, e5[2021-10-02]. https://doi.org/10.1016/j.neuron. 2019.10.033.
[20] SMITH A J,YAO X,DIX J A,et al. Test of the |
[1] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[2] | HAN Guangsong, NI Jun. Advances in Clinical Classification of Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(10): 1120-1126. |
[3] | CHENG Anqi, XU Weihai. Advances in Genetics of Stroke in Young Adults [J]. Chinese Journal of Stroke, 2022, 17(09): 920-924. |
[4] | XU Luyao, CHEN Xiaodi, LIANG Zhigang. Advances in Imaging Evaluation of Post-stroke Aphasia [J]. Chinese Journal of Stroke, 2022, 17(09): 1017-1021. |
[5] | LIU Yonghui, YANG Kan, QIN Fubin, CHEN Wenwen, HE Tingting, HUANG Yadi. Progress of Headache due to Reversible Cerebral Vasoconstriction Syndrome [J]. Chinese Journal of Stroke, 2022, 17(05): 455-460. |
[6] | LU Jiajie, ZHAO Hongru. Headache Phenotypes and Possible Mechanisms of Dural Arteriovenous Fistula [J]. Chinese Journal of Stroke, 2022, 17(05): 461-465. |
[7] | WENG Jiaxu, QIU Xin, LI Zixiao. Progress of the Relationship between TET2 Mutation Related Clonal Hematopoiesis of Indeterminate Potential and Stroke [J]. Chinese Journal of Stroke, 2022, 17(04): 413-417. |
[8] | XU Zhe, CHENG Si, LIU Yang, SHI Yanfeng, LI Hao. Construction of Bioinformatics Pipeline for Genomics Data in Cerebral Vascular Disease Researches [J]. Chinese Journal of Stroke, 2022, 17(03): 217-226. |
[9] | LIU Yang, XU Zhe, CHENG Si, SHI Yanfeng, LIN Jinxi, MENG Xia, JIANG Yong, LI Hao. Clinical Research-Oriented Gene Sequencing Projects: Rationale, Management and Quality Control Standards [J]. Chinese Journal of Stroke, 2022, 17(03): 227-235. |
[10] | GUO Songtao, E Bu, LI Zhiqiang, JIANG Hao, XU Yuzhu, SUN Jian, SHI Jianmin, WU Xi, GUO Wei. Advances in the Application of 5G Mobile Stroke Unit [J]. Chinese Journal of Stroke, 2022, 17(02): 113-117. |
[11] | WANG Aimin, WANG Xianling. Progress in the Pathogenesis of Post-stroke of Emotional Instability [J]. Chinese Journal of Stroke, 2021, 16(12): 1284-1289. |
[12] | CHENG Si, XU Zhe, ZUO Ying-Ting, LIU Yang, WANG An-Xin, SHI Yan-Feng, LI Hao, WANG Yong-Jun. Association between Zinc Finger Homeobox 3 Gene Polymorphism and Outcomes in Different Ischemic StrokeSubtypes [J]. Chinese Journal of Stroke, 2021, 16(11): 1102-1109. |
[13] | YAN Ran, SHANGGUAN Yi, QIU Xin, LI Zi-Xiao. Mechanism of DNMT3A in Atherosclerosis [J]. Chinese Journal of Stroke, 2021, 16(11): 1178-1182. |
[14] | DENG Qi-Le, WU Jie-Hong, CHEN Ji-Xiang. Progress of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in the Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(08): 850-854. |
[15] | GUO Jia-Huan, ZHAO Xing-Quan. Discussions on Pathophysiological Mechanism of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage [J]. Chinese Journal of Stroke, 2021, 16(07): 746-751. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||